Who owns SILVERBACK THERAPEUTICS?
- Ticker: SBTX
- CUSIP Number: 82835w108
Tip: Access positions for across all investors
Analyze quarterly positions in Silverback Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silverback Therapeutics stock
Who bought or sold SILVERBACK THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| OrbiMed Advisors | 8.7M | $31M | 0% | Mar 2022 | ||
| FMR | 3.8M | $13M | 100% | Mar 2022 | ||
| Daniel D. Thurber | 3.0M | $10M | 68% | Mar 2022 | ||
| Nextech Invest | 1.9M | $6.7M | 0% | Mar 2022 | ||
| Nantahala Capital Management | 914k | $3.2M | -9% | Mar 2022 | ||
| Vanguard Group | 823k | $2.9M | 100% | Mar 2022 | ||
| Renaissance Technologies | 671k | $2.4M | 82% | Mar 2022 | ||
| Two Sigma Investments | 401k | $1.4M | 2% | Mar 2022 | ||
| Morgan Stanley | 386k | $1.4M | 100% | Mar 2022 | ||
| Two Sigma Advisers | 371k | $1.3M | 64% | Mar 2022 | ||
| Geode Capital Management | 363k | $1.3M | -8% | Mar 2022 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Silverback Therapeutics? |
||||||
| Ensign Peak Advisors | 346k | $1.2M | -16% | Mar 2022 | ||
| State Street Corporation | 344k | $1.2M | 6% | Mar 2022 | ||
| EcoR1 Capital | 330k | $1.2M | -69% | Mar 2022 | ||
| Prosight Management | 325k | $1.1M | 505% | Mar 2022 | ||
| T. Rowe Price Associates | 301k | $1.1M | 0% | Mar 2022 | ||
| Silverarc Capital Management | 209k | $887k | 100% | Jun 2022 | ||
| Citadel Advisors | 195k | $685k | 109% | Mar 2022 | ||
| D. E. Shaw & Co | 187k | $658k | -25% | Mar 2022 | ||
| Northern Trust | 174k | $609k | -3% | Mar 2022 | ||
| Schroder Investment Management Group | 152k | $534k | -6% | Mar 2022 | ||
| Charles Schwab Investment Management | 147k | $518k | -1% | Mar 2022 | ||
| IndexIQ Advisors | 114k | $398k | 100% | Mar 2022 | ||
| Bridgeway Capital Management | 103k | $360k | 100% | Mar 2022 | ||
| Goldman Sachs Group | 102k | $356k | 30% | Mar 2022 | ||
| Ohio Pers | 96k | $337k | 119% | Mar 2022 | ||
| Belvedere Trading | 95k | $407k | 100% | Jun 2022 | ||
| Janney Montgomery Scott | 85k | $297k | 0% | Mar 2022 | ||
| Woodline Partners | 84k | $293k | -83% | Mar 2022 | ||
| Privium Fund Management | 66k | $279k | 100% | Jun 2022 | ||
| Nuveen Asset Management | 65k | $272k | 2% | Mar 2022 | ||
| Bank of New York Mellon | 59k | $206k | -2% | Mar 2022 | ||
| Susquehanna International | 41k | $145k | -32% | Mar 2022 | ||
| Acadian Asset Management | 40k | $139k | -49% | Mar 2022 | ||
| Occudo Quantitative Strategies | 36k | $128k | -38% | Mar 2022 | ||
| Cubist Systematic Strategies | 36k | $127k | -19% | Mar 2022 | ||
| Springbok Capital Management | 34k | $119k | 104% | Mar 2022 | ||
| Honkamp Krueger Financial Services | 32k | $136k | 0% | Jun 2022 | ||
| Marquette Asset Management | 31k | $132k | 100% | Jun 2022 | ||
| Schonfeld Strategic Advisors | 29k | $100k | 100% | Mar 2022 | ||
| Rhumbline Advisers | 24k | $85k | 13% | Mar 2022 | ||
| New York Life Investments Alternatives | 24k | $84k | 100% | Mar 2022 | ||
| GSA Capital Partners | 23k | $80k | 98% | Mar 2022 | ||
| XTX Topco | 22k | $78k | 18% | Mar 2022 | ||
| Parametric Portfolio Associates | 22k | $76k | -46% | Mar 2022 | ||
| Tower Research Capital | 20k | $70k | 609% | Mar 2022 | ||
| Barclays | 17k | $60k | 100% | Mar 2022 | ||
| Jpmorgan Chase & Co | 14k | $50k | -92% | Mar 2022 | ||
| Quattro Financial Advisors | 13k | $45k | 0% | Mar 2022 | ||
| Deutsche Bank Aktiengesellschaft | 11k | $39k | -11% | Mar 2022 | ||
| AQR Capital Management | 11k | $38k | 100% | Mar 2022 | ||
| Etf Managers | 11k | $37k | 0% | Mar 2022 | ||
| American International | 10k | $36k | -7% | Mar 2022 | ||
| California State Teachers Retirement System | 9.0k | $32k | -19% | Mar 2022 | ||
| Russell Investments | 8.4k | $35k | 100% | Jun 2022 | ||
| Quantbot Technologies | 5.4k | $19k | -32% | Mar 2022 | ||
| Wells Fargo & Company | 4.2k | $13k | -51% | Mar 2022 | ||
| NISA Investment Advisors | 4.1k | $14k | 100% | Mar 2022 | ||
| Amalgamated Bank | 2.5k | $9.0k | 100% | Mar 2022 | ||
| Legal & General Group | 1.6k | $6.0k | 0% | Mar 2022 | ||
| Summit Investment Advisors | 1.0k | $4.0k | 0% | Mar 2022 | ||
| UBS Group | 513.00 | $2.9k | -99% | Mar 2022 | ||
| Simplex Trading | 371.00 | $999.993400 | -83% | Mar 2022 | ||
| Ellevest | 243.00 | $999.993600 | 100% | Jun 2022 | ||
| Group One Trading | 200.00 | $1.0k | 100% | Mar 2022 | ||
| New York State Common Retirement Fund | 169.00 | $1.0k | -99% | Jun 2022 | ||
| Captrust Financial Advisors | 146.00 | $999.997800 | 100% | Mar 2022 | ||
| S.A.C. Capital Advisors | 145.00 | $1.0k | 100% | Mar 2022 | ||
| Toronto-Dominion Bank | 2.00 | $0 | 0% | Mar 2022 | ||
Who sold out of Silverback Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| RA Capital Management | Dec 2021 | 1.7M | $12M |
| Endurant Capital Management | Dec 2021 | 84k | $561k |
| Nomura Holdings | Dec 2021 | 69k | $461k |
| Hrt Financial | Dec 2021 | 64k | $423k |
| Jump Financial | Dec 2021 | 38k | $252k |
| Trexquant Investment | Dec 2021 | 31k | $203k |
| Bailard | Mar 2022 | 30k | $106k |
| Bank of America Corporation | Dec 2021 | 24k | $158k |
| HighVista Strategies | Dec 2021 | 22k | $149k |
| Virtu Financial | Dec 2021 | 20k | $135k |
| ExodusPoint Capital Management | Dec 2021 | 19k | $128k |
| PDT Partners | Dec 2021 | 17k | $112k |
| Board of Trustees of The Leland Stanford Junior University | Dec 2021 | 15k | $97k |
| Hohimer Wealth Management | Mar 2022 | 12k | $42k |
| EMC Capital Management | Dec 2021 | 7.2k | $48k |
| Eagle Bay Advisors | Dec 2021 | 5.9k | $42k |
| Us Bancorp | Dec 2021 | 1.8k | $12k |